Acorda Therapeutics Announces Addition to Board of Directors.HAWTHORNE, N.Y. -- Acorda Therapeutics(R) announced today that Steven M. Rauscher, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Oscient Pharmaceuticals, has been elected to the Acorda Board of Directors. Mr. Rauscher joined Oscient Pharmaceuticals in 2000. In 2004, Oscient launched FACTIVE(R) (gemifloxacin mesylate) tablets for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate severity. Prior to joining Oscient, he spent 18 years at Abbott Laboratories in various leadership positions including Vice President of Corporate Licensing; Vice President of Business Development, International Division; and Vice President of Sales, U.S. Pharmaceuticals. Mr. Rauscher holds an MBA from the University of Chicago and received his BS from Indiana University. Ron Cohen cohen or kohen (Hebrew: “priest”) Jewish priest descended from Zadok (a descendant of Aaron), priest at the First Temple of Jerusalem. The biblical priesthood was hereditary and male. , M.D., President and CEO of Acorda Therapeutics, said, "Steve is a proven leader in the pharmaceutical and biotech industries, with deep experience in both biopharmaceutical product development and commercialization. His commercial product experience, in particular, is a timely addition to Acorda as we launch our first marketed product, ZANAFLEX(R) CAPSULES." About Acorda Therapeutics Acorda Therapeutics, a privately-held biotechnology company, is developing therapies for spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. (SCI (Scalable Coherent Interface) An IEEE standard for a high-speed bus that uses wire or fiber-optic cable. It can transfer data up to 1GBytes/sec. (hardware) SCI - 1. Scalable Coherent Interface. 2. UART. ), multiple sclerosis (MS) and related nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency . The Company's marketed products include ZANAFLEX(R)CAPSULES (tizanidine hydrochloride), a short-acting drug indicated for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical-stage product is Fampridine-SR, which is being developed for both MS and SCI. The Company's pipeline includes valrocemide, which it is developing with Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in , Ltd., as well as a number of preclinical products for regeneration and repair of the spinal cord and brain. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion